Prosecution Insights
Last updated: May 29, 2026

Duane Morris LLP - Washington, D.C.

10 pending office actions • 9 clients • 9 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
2
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
1
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 7 days (1)Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (20%)
5
Medium (50%)
2
Easy (20%)
1
Unknown (10%)

Rejection Statute Mix

BucketCases
§101 only2 (20%)
§103 only5 (50%)
§112 only2 (20%)
No statute on record1 (10%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
40% of docket
1
Information Tech
10% of docket
1
Communications
10% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
40% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LYNCH, MEGAN E 2 38.0% +41.2%
OKEBATO, SAHLU 1 76.2% +18.5%
PINDERSKI, JACQUELINE M 1 27.1% +43.5%
HAM, JIEUN 1 50.0% +0.0%
MILLS, DONALD L 1 84.5% +10.4%
LEE, HOI YAN NMN 1 43.1% +77.9%
KAUFMAN, CLAIRE M 1 62.8% +51.3%
TURPIN, ZACHARY MARK 1 0.0% +0.0%
LIU, CHIA-YI 1 27.0% +21.1%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18087612 MOBILE MEDICINE COMMUNICATION PLATFORM AND METHODS AND USES THEREOF MILLS, DONALD L 9d

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18522857 OPHTHALMIC MEDICAL DEVICE FOR TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION AND EVAPORATIVE DRY EYE DISEASE UTILIZING SHEAR THINNING TECHNOLOGY PINDERSKI, JACQUELINE M 100d overdue
17618239 METHODS AND COMPOSITIONS FOR LUNG CANCER DETECTION TURPIN, ZACHARY MARK 53d overdue
14469152 SYSTEM AND METHOD OF EVALUATING AN INVESTMENT PORTFOLIO LIU, CHIA-YI 7d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18566439 CONFIGURATION FOR MUSCLE-STRENGTHENING EXERCISE EQUIPMENT OKEBATO, SAHLU 153d overdue
18522857 OPHTHALMIC MEDICAL DEVICE FOR TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION AND EVAPORATIVE DRY EYE DISEASE UTILIZING SHEAR THINNING TECHNOLOGY PINDERSKI, JACQUELINE M 100d overdue
18530658 SHOE UPPER LYNCH, MEGAN E 19d overdue
14469152 SYSTEM AND METHOD OF EVALUATING AN INVESTMENT PORTFOLIO LIU, CHIA-YI 7d
18087612 MOBILE MEDICINE COMMUNICATION PLATFORM AND METHODS AND USES THEREOF MILLS, DONALD L 9d
17788926 ANTIBODIES BINDING BCMA AND USES THEREOF KAUFMAN, CLAIRE M 29d
17996444 COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE SUBSTITUTED PURINE DERIVATIVES LEE, HOI YAN NMN 33d
19028723 SHOE UPPER LYNCH, MEGAN E 41d

Client Portfolio (9 clients)

Top Art Units

Art UnitApps
37322
26251
37851
16431
24621
16931
16741
16821
36921

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19028723 SHOE UPPER Adidas AG LYNCH, MEGAN E 3732 §103 Final Rejection 41d Pending Jan 17, 2025
18530658 SHOE UPPER Adidas AG LYNCH, MEGAN E 3732 §103 Non-Final OA 19d overdue Pending Dec 06, 2023
18566439 CONFIGURATION FOR MUSCLE-STRENGTHENING EXERCISE EQUIPMENT Functional Patterns Holdings, LLC OKEBATO, SAHLU 2625 §103 Final Rejection 153d overdue Pending Dec 01, 2023
18522857 OPHTHALMIC MEDICAL DEVICE FOR TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION AND EVAPORATIVE DRY EYE DISEASE UTILIZING SHEAR THINNING TECHNOLOGY Eyedetec Medical, Inc. PINDERSKI, JACQUELINE M 3785 §112 Final Rejection 100d overdue Pending Nov 29, 2023
18307215 BISPECIFIC MOLECULES BINDING TIGIT AND VEGF AND USES THEREOF BEIJING MABWORKS BIOTECH CO., LTD HAM, JIEUN 1643 §103 Non-Final OA 71d overdue Pending Apr 26, 2023
18087612 MOBILE MEDICINE COMMUNICATION PLATFORM AND METHODS AND USES THEREOF BR Invention Holding, LLC MILLS, DONALD L 2462 §103 Final Rejection 9d Pending Dec 22, 2022
17996444 COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE SUBSTITUTED PURINE DERIVATIVES Shanghai Huayu Biotechnology Co., Ltd. LEE, HOI YAN NMN 1693 Other Final Rejection 33d Pending Oct 18, 2022
17788926 ANTIBODIES BINDING BCMA AND USES THEREOF BIOSION INC. KAUFMAN, CLAIRE M 1674 §112 Final Rejection 29d Pending Jun 24, 2022
17618239 METHODS AND COMPOSITIONS FOR LUNG CANCER DETECTION Suzhou Hoho Health Co., Ltd. TURPIN, ZACHARY MARK 1682 §101 Final Rejection 53d overdue Pending Dec 10, 2021
14469152 SYSTEM AND METHOD OF EVALUATING AN INVESTMENT PORTFOLIO Matthew James Mikula LIU, CHIA-YI 3692 §101 Final Rejection 7d Pending Aug 26, 2014

Managing Duane Morris LLP - Washington, D.C.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month